Filter
1886
Filtered Results: 1886
Text search:
pharmaceutical
guidelines
Featured
Recommendations
181
New Publications
498
Language
Document type
No document type
969
Studies & Reports
331
Guidelines
322
Strategic & Response Plan
92
Manuals
90
Fact sheets
26
Training Material
24
Situation Updates
14
Resource Platforms
8
Infographics
6
Brochures
3
Online Courses
1
Countries / Regions
Kenya
77
India
77
Ethiopia
70
Global
55
South Africa
52
Nigeria
43
Western and Central Europe
41
Sierra Leone
40
Uganda
39
Namibia
38
Liberia
36
Ghana
31
Tanzania
28
Zambia
28
Rwanda
27
Nepal
26
Malawi
26
Africa
23
Latin America and the Carribbean
22
Bangladesh
20
Ukraine
19
Philippines
19
Zimbabwe
18
Eastern Europe
17
Lesotho
16
Cambodia
16
Indonesia
12
Botswana
11
Myanmar / Burma
11
Eswatini/ Swaziland
11
Syria
9
Germany
9
Congo, Democratic Republic of
9
South–East Asia Region
9
Eastern Europe and Central Asia
9
Asia
8
Brazil
8
Russia
8
Senegal
7
West and Central Africa
7
East and Southern Africa
7
Cameroon
6
Guinea
6
Thailand
5
Haiti
5
South Sudan
5
Benin
4
Chile
4
Albania
4
Burkina Faso
4
Mozambique
4
Middle East and North Africa
4
Western Pacific Region
4
Vietnam
4
China
3
Laos
3
USA
3
United Kingdom
3
Papua New Guinea
3
Sudan
3
Mali
3
Pakistan
3
Tajikistan
2
Fiji
2
Kyrgyzstan
2
Jordan
2
North America
2
Yemen
2
Iraq
2
North Macedonia
1
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Afghanistan
1
Peru
1
Malaysia
1
Bulgaria
1
Armenia
1
Dominican Republic
1
Venezuela
1
Lithuania
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Belize
1
Costa Rica
1
Panama
1
Argentina
1
Lebanon
1
Nicaragua
1
Moldova
1
Egypt
1
Romania
1
Palestine
1
Georgia
1
Central African Republic
1
Honduras
1
Angola
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
812
Clinical Guidelines
134
Public Health
96
Key Resources
94
Women & Child Health
52
Pharmacy & Technologies
36
Capacity Building
12
Annual Report MEDBOX
2
Toolboxes
AMR
190
Pharmacy
176
COVID-19
136
HIV
102
TB
102
Mental Health
92
Rapid Response
57
NTDs
52
NCDs
44
Caregiver
40
Planetary Health
40
Ebola & Marburg
29
Conflict
24
Malaria
23
Global Health Education
21
Health Financing Toolbox
13
Disability
11
Polio
11
Specific Hazards
10
Refugee
7
Natural Hazards
7
Cholera
3
Social Ethics
3
Zika
3
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
SITUATION ANALYSIS AND RECOMMENDATIONS
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
(Health Systems in Transition, Vol. 4, No. 3, 2014)
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order ...
This strategy, produced by IFRC, UNICEF and WHO, provides an overview of RCCE coordination approach and priorities across the different phases of the COVID-19 preparedness and response
WHO/UNICEF/UNFPA joint statement
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Economic Issues, Policies and Option for Action
2nd edition.
The tool kit provides learning objects and curricular content to support the competencies for those proficiency/trainee levels
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson...
Talking About Corona-19
in English and Vietnamese
Informations for Kids
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
